Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Health Tech
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Hims & Hers stock plunged 30% on Monday after Novo Nordisk abruptly ended a collaboration to offer direct access to its weight loss drug Wegovy.
Heather Landi
Jun 23, 2025 12:00pm
New Evernorth program to cap out-of-pocket costs for GLP-1s
May 21, 2025 4:30pm
Fierce Pharma
Novo Nordisk Foundation, China answer call for WHO donations
May 21, 2025 2:30pm
Novo Nordisk taps Hims & Hers, LifeMD and Ro for GLP-1 tie-up
Apr 29, 2025 5:15pm
Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle
Feb 13, 2025 8:00am
Texas sues PBMs, manufacturers over insulin 'conspiracy'
Oct 3, 2024 4:30pm
